CAD Flashcards
Metabolic syndrome
3/5 criteria Abdominal obesity (>= 102 cm men, >= 88 cm in men) TG > 175 HDL < 40 men, < 50 women BP > 130/85 Fasting glucose >= 100
Indication for stress EKG in asymptomatic
CLass IIb
Intermediate risk, particularly when starting exercise program
Indication for asymptomatic stress test with imaging
May be considered when DM, strong FH CHD, previous assessment suggests high risk such as CAC score > 400
Very high risk ASCVD
History of ASCVD
>= 2 events or 1 events and >=2 conditions
Events for ACSVD very high risk
ACS < 12 mo
h/o MI or stroke
Symptomatic PAD
Conditions for ASCVD very high risk
Smoker, DM, HTN LDL >= 100 on max therapy >= 65 Heterozygous FH h/o CABG or PCI CKD GFR 15-59 CHF
Very high risk ASCVD LDL goal
<70
History of ASCVD, not very high risk LDL goal
Lower by 50%
LDL >= 190, primary prevention goal
Lower by 50% or LDL < 100
DM + ASCVD risk > 20% treatment
High intensity statin
DM + ASCVD risk < 20% treatment
Look at risk enhancers
If yes -> high intensity
If not -> moderate
DM risk enhancers for primary prevention
DM2 for 10 yrs, DM1 for 20 yrs Ur albumin >= 30 mcg/mg creat eGFR < 60 Retinopathy, neuropathy ABI < 0.9
LDL < 190, non-DM management age 0-19
Lifestyle
Statin if FH
LDL < 190, non-DM management age 20-39
Lifestyle
If early ASCVD and LDL > 160 -> statin
LDL < 190, non-DM management age 40-75
Risk calculator
ASCVD risk >= 20% treatment
High intensity statin
ASCVD risk <= 5%
Lifestyle
ASCVD risk 5-20% treatment
Borderline, look at risk enhancers
If yes -> moderate statin
If uncertain and 7.5-20 -> CAC
High intensity statin reduction
> =50%
Moderate intensity statin reduction
30-50%
Low intensity statin reduction
<30%
Aspirin primary prevention indication
Class IIb
ASCVD > 20%, maybe >10%, not increased bleeding risk